Induced pluripotent stem cell line (SDQLCHi041-A) from a male patient with mucopolysaccharidosis type IIIB
Jingyun Guan1, Guangyan Tian2, Rui Dong1
1Pediatric Research Institute, Qilu Children's Hospital of Shandong University, Jinan, Shandong 250022, China.
Abstract:
Mucopolysaccharidosis type IIIB (MPS IIIB) is an autosomal recessive metabolic disorder caused by mutations in NAGLU gene, and characterized by progressive cognitive decline and behavioral difficulties and motor function retardation. A human induced pluripotent stem cell line, SDQLCHi041-A was generated from peripheral blood mononuclear cells of a 4 years and 9 months old patient with MPS IIIB, who carried compound heterozygous mutation of c.1336G > A and c.608G > A in NAGLU gene. SDQLCHi041-A offers a useful cell model to investigate pathogenic mechanisms in MPS IIIB.
Insights
Mucopolysaccharidosis type IIIB (MPS IIIB) is a genetic disorder causing cognitive and motor decline. Researchers created a patient-derived stem cell line to study MPS IIIB disease mechanisms.
Area of Science:
- Biochemistry
- Genetics
- Stem Cell Biology
Background:
- Mucopolysaccharidosis type IIIB (MPS IIIB) is an inherited metabolic disorder.
- It results from mutations in the NAGLU gene, leading to severe neurological impairment.
- Characterized by cognitive decline, behavioral issues, and motor retardation.
Purpose of the Study:
- To generate a human induced pluripotent stem cell (hiPSC) line from an MPS IIIB patient.
- To establish a valuable cellular model for investigating MPS IIIB pathogenesis.
Main Methods:
- Generated hiPSC line SDQLCHi041-A from peripheral blood mononuclear cells.
- Patient diagnosed with MPS IIIB and carried compound heterozygous mutations (c.1336G>A and c.608G>A) in the NAGLU gene.
Main Results:
- Successfully generated the SDQLCHi041-A hiPSC line.
- This cell line accurately reflects the genetic makeup of the MPS IIIB patient.
Conclusions:
- The SDQLCHi041-A hiPSC line serves as a crucial tool for MPS IIIB research.
- Facilitates deeper understanding of the molecular mechanisms underlying MPS IIIB.
More Related Videos
07:44CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
10:48Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions
Published on: November 26, 2014
Related Concept Videos
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
EPS and iPS Cells in Disease Research
